Benefit-Risk Assessment in Pharmaceutical Research and Development
Quantifying patient preferences to inform benefit-risk evaluations
Publication
, Chapter
Johnson, FR; Hauber, AB; Zhang, J
November 27, 2013
Duke Scholars
ISBN
9781439867945
Publication Date
November 27, 2013
Start / End Page
37 / 58
Citation
APA
Chicago
ICMJE
MLA
NLM
Johnson, F. R., Hauber, A. B., & Zhang, J. (2013). Quantifying patient preferences to inform benefit-risk evaluations. In Benefit-Risk Assessment in Pharmaceutical Research and Development (pp. 37–58).
Johnson, F. R., A. B. Hauber, and J. Zhang. “Quantifying patient preferences to inform benefit-risk evaluations.” In Benefit-Risk Assessment in Pharmaceutical Research and Development, 37–58, 2013.
Johnson FR, Hauber AB, Zhang J. Quantifying patient preferences to inform benefit-risk evaluations. In: Benefit-Risk Assessment in Pharmaceutical Research and Development. 2013. p. 37–58.
Johnson, F. R., et al. “Quantifying patient preferences to inform benefit-risk evaluations.” Benefit-Risk Assessment in Pharmaceutical Research and Development, 2013, pp. 37–58.
Johnson FR, Hauber AB, Zhang J. Quantifying patient preferences to inform benefit-risk evaluations. Benefit-Risk Assessment in Pharmaceutical Research and Development. 2013. p. 37–58.
ISBN
9781439867945
Publication Date
November 27, 2013
Start / End Page
37 / 58